Muscarinic receptor binding changes in postmortem Parkinson's disease.

about

Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection

P2860

Q58790106-10A42972-BCD6-4CFB-B0E4-E0B37D42DE65

P2860

Muscarinic receptor binding changes in postmortem Parkinson's disease.

Item

http://www.wikidata.org/entity/Q47871275

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@en

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@nl

type

Item

label

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@en

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@nl

prefLabel

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@en

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@nl

P1476

Muscarinic receptor binding changes in postmortem Parkinson's disease.

@en

P2093

Brian Dean

http://www.w3.org/2001/XMLSchema#string

Elizabeth Scarr

http://www.w3.org/2001/XMLSchema#string

Geoff Pavey

http://www.w3.org/2001/XMLSchema#string

Malcolm Horne

http://www.w3.org/2001/XMLSchema#string

P2860

Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control

Cognitive and motor shifting aptitude disorder in Parkinson's disease.

The M3-muscarinic receptor regulates learning and memory in a receptor phosphorylation/arrestin-dependent manner

Rivastigmine for dementia associated with Parkinson's disease.

Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.

A computational neuroanatomy for motor control

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?

P2888

s00702-016-1629-z

P304

227-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00702-016-1629-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

C A McLean

Caitlin McOmish

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27873015

http://www.w3.org/2001/XMLSchema#string

Muscarinic receptor binding changes in postmortem Parkinson's disease.

about

P2860

P2860

Muscarinic receptor binding changes in postmortem Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698